TNF and rheumatoid arthritis: Thus, decreased levels of circulating HS/H, along with significantly decreased disease activity markers, such as DAS28, CRP and ESR, under anti-TNF-α treatment indicate that only good control of disease activity in RA can improve HSPGs/HS metabolism and delay cardiovascular events.